Speaking of Science

» innovation, art, disease/medicine and genomics

Most Recent

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: Speaking of Science

Speaking of Science

By | February 1, 2016

February 2016's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | December 1, 2014

December 2014's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | May 1, 2014

May 2014's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | April 1, 2014

April 2014's selection of notable quotes

2 Comments

image: Speaking of Science

Speaking of Science

By | February 1, 2014

February 2014's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2012

October 2012's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2012

August 2012's selection of notable quotes

3 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2012

July 2012's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | June 1, 2012

June 2012's selection of notable quotes

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham